Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation

PaperCitations, authors & open-access status

Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 85 citations, 2023 year and closed oa status.

85
Citations
2023
Year
closed
OA Status

Related on ScholarIQ

Vijay Patil
Author
Atanu Bhattacharjee
Author
Journal of Clinical Oncology
Journal
Head and Neck Cancer Studies
Topic
Head and Neck Cancer Studies
Topic
Oral health in cancer treatment
Topic
470M+ articles · free account